Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Maron

Showing results (1-10 of 536) with videos related to

Pageof 54
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|October 22, 2010
Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathyBarry J Maron
Heart Rhythm|July 31, 2010
Diversity of views from Europe on national preparticipation screening for competitive athletesBarry J Maron
Progress in Cardiovascular Diseases|June 13, 2012
Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelinesBarry J Maron
Circulation|January 27, 2010
Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
The American Journal of Cardiology|November 21, 2017
Harvey Feigenbaum, MD, and the Creation of Clinical Echocardiography: A Conversation With Barry J. Maron, MDBarry J Maron
Heart Rhythm|January 30, 2026
The first evidence that implantable defibrillators are effective and reliable for prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
The American Journal of Cardiology|February 4, 2014
Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common, and treatable disease (from the International Summit V)Barry J Maron
Cardiac Electrophysiology Clinics|May 24, 2015
Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
JAMA Cardiology|July 21, 2016
Saving Lives One at a TimeBarry J Maron
Circulation|July 11, 2007
Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathyBarry J Maron
Pageof 54

Showing results (1-10 of 536) with videos related to

Sort By:
Pageof 54
Circulation Journal : Official Journal of the Japanese Circulation Society|October 22, 2010
Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathyBarry J Maron
Heart Rhythm|July 31, 2010
Diversity of views from Europe on national preparticipation screening for competitive athletesBarry J Maron
Progress in Cardiovascular Diseases|June 13, 2012
Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelinesBarry J Maron
Circulation|January 27, 2010
Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
The American Journal of Cardiology|November 21, 2017
Harvey Feigenbaum, MD, and the Creation of Clinical Echocardiography: A Conversation With Barry J. Maron, MDBarry J Maron
Heart Rhythm|January 30, 2026
The first evidence that implantable defibrillators are effective and reliable for prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
The American Journal of Cardiology|February 4, 2014
Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common, and treatable disease (from the International Summit V)Barry J Maron
Cardiac Electrophysiology Clinics|May 24, 2015
Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathyBarry J Maron
JAMA Cardiology|July 21, 2016
Saving Lives One at a TimeBarry J Maron
Circulation|July 11, 2007
Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathyBarry J Maron
Pageof 54